EGFR essential for the development of pancreatic cancer

The epidermal growth factor receptor (EGFR) gene is essential for KRAS-driven pancreatic cancer development, according to study results presented at the Second AACR International Conference on Frontiers in Basic Cancer Research, held here Sept. 14-18, 2011.

The mutation of the KRAS gene has been found to be an important component in the development of many cancers, including . However, Barbara M. Gruener, researcher at the Technical University in Munich, Germany, said that despite the presence of KRAS, the development of preneoplastic precursor lesions and pancreatic is blocked without the EGF receptor.

"These results revealed an unappreciated central role of EGFR very early in the carcinogenic process," said Gruener, who is a doctoral student at the university.

Gruener and colleagues compared more than 40 mice with the pancreas-specific deletion of EGFR with the KRAS mouse model for pancreatic cancer.

"Contrary to current opinion, we showed that lack of EGFR blocks the development of pancreatic cancer," she said. "Originally, we wanted to characterize the known role of EGFR in pancreatic cancer to a higher extent so that EGFR targeted therapy could be more individualized."

Gruener said the results were not what researchers had expected and were surprising.

"With oncogenic active KRAS, you would expect that the lack of a receptor that is upstream of the KRAS signaling pathway does not impair the carcinogenic effects of KRAS almost completely," she said.

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Colon cancer rates rising among Americans under 50

1 hour ago

(HealthDay)—Although the overall rate of colon cancer has fallen in recent decades, new research suggests that over the last 20 years the disease has been increasing among young and early middle-aged American ...

The future of precision immunology

5 hours ago

In his State of the Union address, President Obama announced a new precision medicine initiative to work on finding a cure for cancer and other diseases. Howard L. Kaufman, a leading immunotherapy expert ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.